1Maakaroun NR, Moanna A, Jacob JT, et al. Viral infections associated with haemophagocytic syndrome[J]. Rev Med Virol, 2010, 20(2): 93-105.
2Henter JI, Home A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
3Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J]. Crit Rev Oncol Hematol, 2002, 44(3): 259-272.
4Rivière S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients[J]. Am J Med, 2014, 127(11): 1118-1125.
5Johnson TS, Terrell CE, Millen SH, et al. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis[J]. J Immunol, 2014, 192(1): 84-91.
6Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center[J]. Med Pediatr Oncol, 2003, 41(2): 103-109.
7Henter JI, Samuelsson-Home A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation[J]. Blood, 2002, 100(7): 2367-2373.
8Ahn JS, Rew SY, Shin MG, et al. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis[J]. Am J Hematol, 2010, 85(9): 719-722.
9Ohga S, Kudo K, Ishii E, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan[J]. Pediatr Blood Cancer, 2010, 54(2): 299-306.
